We are live on
!
Find out more
H
HoyleCohen Portfolio holdings
AUM
$1.32B
1-Year Est. Return
27.05%
This Fund
S&P 500
This Quarter
Est. Return
+10.28%
1 Year Est. Return
+27.05%
3 Year Est. Return
+46.07%
5 Year Est. Return
+145.61%
10 Year Est. Return
–
AUM
$629M
AUM Growth
+$43M
(+7.3%)
Cap. Flow
-$9.68M
Cap. Flow
% of AUM
-1.54%
Top 10 Holdings %
Top 10 Hldgs %
31.07%
Holding
200
New
10
Increased
51
Reduced
94
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.07M |
| 2 |
ProShares UltraShort Dow 30
DXD
|
+$536K |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$511K |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$298K |
| 5 |
American Tower
AMT
|
+$228K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$3.65M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.43M |
| 3 |
FOCS
Focus Financial Partners Inc. Class A
FOCS
|
+$639K |
| 4 |
ProShares UltraShort S&P500
SDS
|
+$590K |
| 5 |
Apple
AAPL
|
+$514K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.18% |
| 2 | Financials | 12.6% |
| 3 | Communication Services | 9.36% |
| 4 | Healthcare | 8.82% |
| 5 | Industrials | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
iShares MSCI ACWI ETF
ACWI
$32.6B
| $1.13M | 0.18% |
14,260
-1,130
| -7% | -$86.4K |
|
102
California Water Service
CWT
$3.04B
| $1.13M | 0.18% |
21,907
| – | – |
|
103
SPDR Gold Trust
GLD
$131B
| $1.12M | 0.18% |
7,851
-700
| -8% | -$97.8K |
|
104
Vornado Realty Trust
VNO
$7.47B
| $1.08M | 0.17% |
16,191
-951
| -6% | -$61.5K |
|
105
Ross Stores
ROST
$76.6B
| $1.05M | 0.17% |
9,061
-1,160
| -11% | -$131K |
|
106
iShares MSCI EAFE ETF
EFA
$76.4B
| $1.02M | 0.16% |
14,742
+40
| +0.3% | +$2.7K |
|
107
Alerian MLP ETF
AMLP
$13B
| $1M | 0.16% |
23,532
-8,794
| -27% | -$369K |
|
108
Vanguard Small-Cap Value ETF
VBR
$37.1B
| $998K | 0.16% |
7,279
+196
| +3% | +$26K |
|
109
Vanguard Total International Stock ETF
VXUS
$153B
| $979K | 0.16% |
17,578
+844
| +5% | +$45.4K |
|
110
Altria Group
MO
$122B
| $918K | 0.15% |
18,400
-500
| -3% | -$23.6K |
|
111
iShares Russell 2000 ETF
IWM
$80.9B
| $860K | 0.14% |
5,191
-346
| -6% | -$54.7K |
|
112
CVS Health
CVS
$137B
| $852K | 0.14% |
11,465
| – | – |
|
113
Eli Lilly
LLY
$1.07T
| $848K | 0.13% |
6,451
+41
| +0.6% | +$4.75K |
|
114
Schwab U.S Small- Cap ETF
SCHA
$22.5B
| $841K | 0.13% |
44,488
+1,584
| +4% | +$28.7K |
|
115
Brookfield
BN
$102B
| $835K | 0.13% |
40,502
-987
| -2% | -$19.7K |
|
116
Deere & Co
DE
$170B
| $833K | 0.13% |
4,810
-255
| -5% | -$43.9K |
|
|
NBL
117
DELISTED
Noble Energy, Inc.
NBL
| $812K | 0.13% |
32,680
-4,500
| -12% | -$95.6K |
|
118
Zions Bancorporation
ZION
$10.1B
| $793K | 0.13% |
15,275
| – | – |
|
119
PepsiCo
PEP
$186B
| $785K | 0.12% |
5,744
-383
| -6% | -$52.1K |
|
120
Las Vegas Sands
LVS
$30.5B
| $766K | 0.12% |
11,095
-1,700
| -13% | -$106K |
|
121
Amgen
AMGN
$203B
| $760K | 0.12% |
3,153
| – | – |
|
122
Starbucks
SBUX
$118B
| $710K | 0.11% |
8,074
| – | – |
|
|
MMP
123
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $704K | 0.11% |
11,205
-225
| -2% | -$14K |
|
124
Energy Transfer Partners
ET
$70.1B
| $692K | 0.11% |
53,922
-3,691
| -6% | -$45.5K |
|
125
Southern Company
SO
$110B
| $681K | 0.11% |
10,690
-75
| -0.7% | -$4.65K |
|
Similar funds
PRIG
HIG
PO
BPCA
GP
AT
KI
CDH
HoyleCohen's Q4 2019 Portfolio in Review
As of Q4 2019, HoyleCohen held 200 positions worth $629M, up 7.3% from $586M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
HoyleCohen's Q4 2019 filing shows 10 new, 51 increased, 94 reduced and 5 closed positions. Its largest new stake was ProShares UltraShort Dow 30: 4,400 shares worth $496K. The largest sale was Celgene Corp, an estimated $3.65M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- HoyleCohen's largest Q4 2019 buy was ProShares UltraShort Dow 30: 4,400 shares worth $496K.
- HoyleCohen added most to Bristol-Myers Squibb in Q4 2019, an estimated $2.07M increase.
- HoyleCohen's biggest Q4 2019 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $1.43M.
- HoyleCohen fully exited Celgene Corp in Q4 2019, selling an estimated $3.65M.
- HoyleCohen's ten largest holdings make up 31% of its $629M portfolio in Q4 2019.
- HoyleCohen opened 10 new positions and closed 5 in Q4 2019.
- HoyleCohen's portfolio value rose 7.3% quarter-over-quarter to $629M.
Based on HoyleCohen's 13F filing for Q4 2019, filed 10 Feb 2020.